Kaposi Sarcoma Incidence Increasing in Black Men, Decreasing in White Men
The incidence of Kaposi sarcoma is increasing among Black men and decreasing among White men in the United States, a study suggests.
Sarcoma
Shorter Regimen of Radiotherapy Safe for Soft Tissue Sarcoma
None of the patients had grade 3 or higher acute radiation toxicity.
MYC Inhibitor Can Stave Off Progression in Patients With Advanced Solid Tumors
In a first-in-human trial of patients with solid tumors, a MYC inhibitor appeared tolerable and enabled nearly half of evaluable patients to maintain stable disease.
Predicting the Risk of Thoracic Soft Tissue Sarcoma After Breast Cancer
There are several factors that may increase the risk of thoracic soft tissue sarcoma in patients with a history of breast cancer.
COVID-19 Vaccination Should Not Interrupt ICI Therapy, Researchers Say
COVID-19 vaccination is safe for cancer patients receiving immune checkpoint inhibitors and should not interrupt therapy, according to researchers.
Treatment Changes May Have Reduced Rates of Invasive Breast Cancer in Childhood Cancer Survivors
The incidence of invasive breast cancer among childhood cancer survivors decreased from the 1970s to the 1990s.
Adding Ifosfamide to MAP Provides No Benefit in High-Grade Osteosarcoma
Phase 3 data do not support adding ifosfamide to adjuvant methotrexate, doxorubicin, and cisplatin in patients with high-grade osteosarcoma.
Improving the Rate of Serious Illness Conversations at Oncology Clinics
Researchers sought to increase the rate of serious illness conversations between clinicians and patients with cancer.
Retevmo Approved for RET-Driven Solid Tumors, NSCLC
The approvals were based on data from the LIBRETTO-001 trial.
Cabazitaxel Appears Active in Advanced Dedifferentiated Liposarcoma
Cabazitaxel demonstrated antitumor activity in patients with previously treated, advanced dedifferentiated liposarcoma in a phase 2 trial.
- Loading...
Loading...
Next post in Sarcoma
Loading... 
Loading...